The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Intrinsic subtype and its clinical significance in early node-negative breast cancer: Results from two randomized trials of adjuvant chemoendocrine therapy.
Ewan K.A Millar
No relevant relationships to disclose
Alan Stuart Coates
No relevant relationships to disclose
Sandra O'Toole
No relevant relationships to disclose
Cristina Selinger
No relevant relationships to disclose
Elizabeth A. Musgrove
No relevant relationships to disclose
Max Yan
No relevant relationships to disclose
Giuseppe Viale
No relevant relationships to disclose
Meredith M. Regan
No relevant relationships to disclose
Karen N. Price
No relevant relationships to disclose
Zhuoxin Sun
No relevant relationships to disclose
Monica M. Castiglione
No relevant relationships to disclose
Marco Colleoni
No relevant relationships to disclose
Richard D. Gelber
No relevant relationships to disclose
Aron Goldhirsch
No relevant relationships to disclose
Robert L. Sutherland
No relevant relationships to disclose